• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原向血凝块的渐进性吸附与其溶解敏感性之间的相关性。

Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis.

作者信息

Sabovic M, Lijnen H R, Keber D, Collen D

机构信息

Center for Thrombosis and Vascular Research, University of Leuven, Belgium.

出版信息

Thromb Haemost. 1990 Nov 30;64(3):450-4.

PMID:2096491
Abstract

The binding of plasminogen to preformed human plasma clots immersed in citrated human plasma was measured and correlated with the sensitivity of these clots to lysis with recombinant tissue-type plasminogen activator (rt-PA), recombinant single-chain urokinase-type plasminogen activator (rscu-PA) or two chain urokinase-type plasminogen activator (tcu-PA, urokinase). When 0.15 ml plasma clots were compressed mechanically to about 1% of their original weight, and immersed in 0.15 ml plasma, 131I-labeled native plasminogen (Glu-plasminogen) adsorbed progressively from the plasma milieu onto the clot; binding was 3 +/- 1% (n = 10) after 1 h, 7 +/- 1% after 12 h and 12 +/- 1% after 48 h. This was associated with an increased sensitivity of the clot to lysis; 50% clot lysis in 4 h was obtained with 65 +/- 5 ng/ml (n = 3) rt-PA before and 30 +/- 5 ng/ml (n = 3) after 48 h preincubation in plasma (p less than 0.01), with corresponding values of 660 +/- 55 ng/ml (n = 3) and 280 +/- 25 ng/ml (n = 3) for rscu-PA, (p less than 0.01), and 800 +/- 85 ng/ml (n = 3) and 270 +/- 35 ng/ml (n = 3) for urokinase (p less than 0.01). Additional binding of plasminogen and increased sensitivity to lysis were reduced or abolished when the clot was preincubated in plasminogen-depleted or in t-PA-depleted plasma, or when 20 mM 6-aminohexanoic acid or 2,000 KIU/ml aprotinin were added.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

检测了纤溶酶原与浸泡在枸橼酸化人血浆中的预先形成的人血浆凝块的结合情况,并将其与这些凝块对重组组织型纤溶酶原激活剂(rt-PA)、重组单链尿激酶型纤溶酶原激活剂(rscu-PA)或双链尿激酶型纤溶酶原激活剂(tcu-PA,尿激酶)溶解的敏感性相关联。当将0.15 ml血浆凝块机械压缩至其原始重量的约1%,并浸泡在0.15 ml血浆中时,131I标记的天然纤溶酶原(Glu-纤溶酶原)从血浆环境中逐渐吸附到凝块上;1小时后结合率为3±1%(n = 10),12小时后为7±1%,48小时后为12±1%。这与凝块对溶解的敏感性增加有关;在血浆中预孵育48小时前,用65±5 ng/ml(n = 3)rt-PA可在4小时内实现50%的凝块溶解,预孵育后为30±5 ng/ml(n = 3)(p<0.01),rscu-PA的相应值为660±55 ng/ml(n = 3)和280±25 ng/ml(n = 3)(p<0.01),尿激酶为800±85 ng/ml(n = 3)和270±35 ng/ml(n = 3)(p<0.01)。当凝块在纤溶酶原缺乏或t-PA缺乏的血浆中预孵育时,或当加入20 mM 6-氨基己酸或2000 KIU/ml抑肽酶时,纤溶酶原的额外结合以及对溶解的敏感性增加会降低或消除。(摘要截断于250字)

相似文献

1
Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis.纤溶酶原向血凝块的渐进性吸附与其溶解敏感性之间的相关性。
Thromb Haemost. 1990 Nov 30;64(3):450-4.
2
Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.回缩对使用纤维蛋白特异性和非纤维蛋白特异性纤溶酶原激活剂溶解人血凝块的影响。
Thromb Haemost. 1989 Dec 29;62(4):1083-7.
3
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(scu-PA)和尿激酶在体外血浆环境中对血凝块溶解不存在协同作用。
Thromb Haemost. 1986 Aug 20;56(1):35-9.
4
Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasma.α2-抗纤溶酶在人血浆中与单链尿激酶型纤溶酶原激活剂进行纤维蛋白特异性凝块溶解中的作用。
Thromb Haemost. 1991 Apr 8;65(4):394-8.
5
Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.赖氨酸纤溶酶原对单链或双链尿激酶型纤溶酶原激活剂或组织型纤溶酶原激活剂所致血凝块溶解的增强作用。
Thromb Haemost. 1989 Jun 30;61(3):502-6.
6
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.体外凝块溶解作为血栓对纤维蛋白溶解抵抗的潜在指标——在健康受试者中的研究及其与血液纤溶参数的相关性
Thromb Haemost. 1997 Apr;77(4):725-9.
7
Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).添加不同浓度重组组织型纤溶酶原激活剂(Rt-PA)后新生儿和成人全血凝块的溶解情况。
Semin Thromb Hemost. 1998;24(6):599-604. doi: 10.1055/s-2007-996060.
8
Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.由组织型纤溶酶原激活剂的NH2末端区域和尿激酶型纤溶酶原激活剂的COOH末端区域组成的嵌合纤溶酶原激活剂在纯化系统和人血浆中的抑制作用。
Thromb Haemost. 1988 Oct 31;60(2):247-50.
9
Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential.体外或溶栓治疗期间纤溶酶原的消耗会限制纤溶潜力。
J Lab Clin Med. 1992 Jul;120(1):120-8.
10
Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.组织型纤溶酶原激活剂可增加谷氨酸纤溶酶原与血栓的结合。
J Clin Invest. 1984 Dec;74(6):2009-16. doi: 10.1172/JCI111623.

引用本文的文献

1
Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model.血栓回缩会影响体外猪血栓模型中超声增强溶栓的程度。
Ultrasound Med Biol. 2013 May;39(5):813-24. doi: 10.1016/j.ultrasmedbio.2012.12.008. Epub 2013 Mar 1.
2
Comparison of plasmin with recombinant tissue-type plasminogen activator in lysis of cerebral thromboemboli retrieved from patients with acute ischemic stroke.比较纤溶酶与重组组织型纤溶酶原激活剂在急性缺血性脑卒中患者脑血栓栓子溶解中的作用。
Stroke. 2011 Aug;42(8):2222-8. doi: 10.1161/STROKEAHA.110.609198. Epub 2011 Jun 23.
3
Hybrid treatment with angiographic catheter in massive pulmonary embolism: mechanical fragmentation and fibrinolysis.
血管造影导管在大面积肺栓塞中的混合治疗:机械破碎与纤维蛋白溶解
Radiol Med. 2007 Sep;112(6):837-49. doi: 10.1007/s11547-007-0191-z. Epub 2007 Sep 20.
4
Morphologic characteristics of central pulmonary thromboemboli predict haemodynamic response in massive pulmonary embolism.
Intensive Care Med. 2004 Aug;30(8):1552-6. doi: 10.1007/s00134-004-2314-5. Epub 2004 Jun 12.
5
Inner clot diffusion and permeation during fibrinolysis.纤维蛋白溶解过程中的内部凝块扩散与渗透。
Biophys J. 1993 Dec;65(6):2622-43. doi: 10.1016/S0006-3495(93)81314-6.
6
Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.组织型纤溶酶原激活剂(tPA)抑制纤溶酶对纤维蛋白的降解。该机制可减缓tPA介导的纤维蛋白溶解,但不需要α2-抗纤溶酶或内源性纤溶酶原的泄漏。
J Clin Invest. 1995 Jun;95(6):2483-90. doi: 10.1172/JCI117949.